… to SARS-CoV-2 infection. Here, we collected blood from COVID-19 patients who have
recently become virus-free, and therefore were discharged, and detected SARS-CoV-2-specific …

… Plasma samples from 20 convalescent patients with confirmed COVID-19 infection were
collected for this study. All plasmas were collected between March and May 2020 where only …

… This study described the longitudinal distribution of anti-SARS-CoV-2 antibodies in COVID-19
patients at 11 months after the onset. Moreover, we observed NAbs in these recovered …

… therapeutic against SARS coronavirus 2 (SARS-CoV-2; the causative organism in COVID-19). …
Use of this agent in patients with COVID-19 over 7–14 days, for example, suggests side-…

… 20 convalescent patients and incubated the authentic SARS-CoV-2 wild-type (WT) virus for
… ELISA) showed that all plasmas collected bound the SARS-CoV-2 S-protein trimer and most …

… Similarly, slow decay of SARS-CoV-2-specific memory T cells is expected. In the present …
of SARS-CoV-2-specific memory T cell responses in COVID-19 convalescent patients over 10 …

… of vaccines against this emerging virus. In this study, we aimed to assess the dynamics and
longevity of the SARS-CoV-2-specific immune responses in COVID-19 patients with a broad …

… rate of COVID-19. Precise diagnosis of COVID-19 with RT-PCR detection of SARS-CoV-2 …
an overwhelming Ab response may even aggravate COVID-19 infection in patients (14). …

… Recent study indicated that antibodies against SARS-CoV-2 did not … SARS-CoV-2 in serial
blood samples collected from 52 confirmed COVID-19 patients during the convalescent phase …

… acute and convalescent donors suggests that epitope characterization of convalescent
donor … in COVID-19 patients. The central role of inflammation in the pathogenesis of severe …